Zemel R - Search Results

1

25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism.

Ravid A, Rapaport N, Issachar A, Erman A, Bachmetov L, Tur-Kaspa R, Zemel R. Ravid A, et al. Among authors: zemel r. Int J Mol Sci. 2019 May 13;20(9):2367. doi: 10.3390/ijms20092367. Int J Mol Sci. 2019. PMID: 31086078 Free PMC article.

2

p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.

Zemel R, Koren C, Bachmatove L, Avigad S, Kaganovsky E, Okon E, Ben-Ari Z, Grief F, Ben-Yehoyada M, Shaul Y, Tur-Kaspa R. Zemel R, et al. Dig Dis Sci. 2002 Apr;47(4):716-22. doi: 10.1023/a:1014767311799. Dig Dis Sci. 2002. PMID: 11991598

3

A novel high throughput screening assay for HCV NS3 serine protease inhibitors.

Berdichevsky Y, Zemel R, Bachmatov L, Abramovich A, Koren R, Sathiyamoorthy P, Golan-Goldhirsh A, Tur-Kaspa R, Benhar I. Berdichevsky Y, et al. Among authors: zemel r. J Virol Methods. 2003 Feb;107(2):245-55. doi: 10.1016/s0166-0934(02)00255-0. J Virol Methods. 2003. PMID: 12505640

4

Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodies.

Zemel R, Berdichevsky Y, Bachmatov L, Benhar I, Tur-Kaspa R. Zemel R, et al. J Hepatol. 2004 Jun;40(6):1000-7. doi: 10.1016/j.jhep.2004.02.026. J Hepatol. 2004. PMID: 15158342

5

HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.

Gal-Tanamy M, Zemel R, Berdichevsky Y, Bachmatov L, Tur-Kaspa R, Benhar I. Gal-Tanamy M, et al. Among authors: zemel r. J Mol Biol. 2005 Apr 15;347(5):991-1003. doi: 10.1016/j.jmb.2005.02.020. J Mol Biol. 2005. PMID: 15784258

6

Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection.

Cohen M, Bachmatov L, Ben-Ari Z, Rotman Y, Tur-Kaspa R, Zemel R. Cohen M, et al. Among authors: zemel r. Dig Dis Sci. 2007 Sep;52(9):2427-32. doi: 10.1007/s10620-006-9630-2. Epub 2007 Apr 10. Dig Dis Sci. 2007. PMID: 17436105

7

Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions.

Shemer-Avni Y, Cohen M, Keren-Naus A, Sikuler E, Hanuka N, Yaari A, Hayam E, Bachmatov L, Zemel R, Tur-Kaspa R. Shemer-Avni Y, et al. Among authors: zemel r. Clin Infect Dis. 2007 Aug 15;45(4):e32-8. doi: 10.1086/520014. Epub 2007 Jul 10. Clin Infect Dis. 2007. PMID: 17638183

8

Inhibition of hepatitis C virus RNA replicons by peptide aptamers.

Trahtenherts A, Gal-Tanamy M, Zemel R, Bachmatov L, Loewenstein S, Tur-Kaspa R, Benhar I. Trahtenherts A, et al. Among authors: zemel r. Antiviral Res. 2008 Mar;77(3):195-205. doi: 10.1016/j.antiviral.2007.12.013. Epub 2008 Jan 22. Antiviral Res. 2008. PMID: 18243349

9

Expression of liver-specific markers in naïve adipose-derived mesenchymal stem cells.

Zemel R, Bachmetov L, Ad-El D, Abraham A, Tur-Kaspa R. Zemel R, et al. Liver Int. 2009 Oct;29(9):1326-37. doi: 10.1111/j.1478-3231.2009.02054.x. Epub 2009 Jun 5. Liver Int. 2009. PMID: 19515222

10

Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.

Gal-Tanamy M, Zemel R, Bachmatov L, Jangra RK, Shapira A, Villanueva RA, Yi M, Lemon SM, Benhar I, Tur-Kaspa R. Gal-Tanamy M, et al. Among authors: zemel r. Antiviral Res. 2010 Oct;88(1):95-106. doi: 10.1016/j.antiviral.2010.08.001. Epub 2010 Aug 10. Antiviral Res. 2010. PMID: 20705106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page